ITU Unit Action

STESSO PHARMACEUTICALS

Auriga Laboratories, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 76666424 FILING DATE 09/21/2006
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY DEFORD, JEFFREY S
L.O. ASSIGNED 115

PUB INFORMATION

RUN DATE 04/07/2009
PUB DATE 06/10/2008
STATUS 606-ABANDONED - NO STATEMENT OF USE FILED
STATUS DATE 04/06/2009
LITERAL MARK ELEMENT STESSO PHARMACEUTICALS

DATE ABANDONED 04/06/2009 DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT STESSO PHARMACEUTICALS
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Auriga Laboratories, Inc.
ADDRESS 5555 Triangle Parkway, Suite 300
Norcross, GA 30092
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Prescription and non-prescription medications and supplements, namely, dietetic and nutritional substances, namely, supplements for medical use and vitamins, pain medications, antihistamines, decongestants, eardrops, eye drops, expectorants, liquid antitussives, cardiovascular and cardiology medications, preparations for treating metabolic disorders, anticholinergics, preparations for treating gasteroenterology conditions, preparations for topical use on the scalp, namely, medicated shampoos and lotions, preparations for treating dermatological conditions, preparations for treating oncology conditions, preparations for treating neurology conditions, preparations for treating urinary tract infections, and preparations for treating oral conditions, namely, xerostomia

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DISCLAIMER W/PREDETER TXT "PHARMACEUTICALS"
TRANSLATION The foreign wording in the mark translates into English as SAME. The wording "Stesso" has no meaning in a foreign language.

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
04/06/2009 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED 037
04/06/2009 ABN6 S ABANDONMENT - NO USE STATEMENT FILED 036
09/02/2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT 035
06/10/2008 PUBO A PUBLISHED FOR OPPOSITION 034
05/21/2008 NPUB O NOTICE OF PUBLICATION 033
05/03/2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 032
05/02/2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 031
05/02/2008 XAEC I EXAMINER'S AMENDMENT ENTERED 030
05/02/2008 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 029
05/02/2008 GNEA O EXAMINERS AMENDMENT E-MAILED 028
05/02/2008 CNEA R EXAMINERS AMENDMENT -WRITTEN 027
04/08/2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 026
04/08/2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 025
04/07/2008 ALIE A ASSIGNED TO LIE 024
03/31/2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 023
03/31/2008 PETG O PETITION TO REVIVE-GRANTED 022
03/31/2008 PROA I TEAS PETITION TO REVIVE RECEIVED 021
01/31/2008 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND 020
01/31/2008 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE 019
11/14/2007 ARAA I ATTORNEY REVOKED AND/OR APPOINTED 018
11/14/2007 REAP I TEAS REVOKE/APPOINT ATTORNEY RECEIVED 017
07/05/2007 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED 016
07/05/2007 GNFR O FINAL REFUSAL E-MAILED 015
07/05/2007 CNFR R FINAL REFUSAL WRITTEN 014
06/05/2007 ARAA I ATTORNEY REVOKED AND/OR APPOINTED 013
06/05/2007 REAP I TEAS REVOKE/APPOINT ATTORNEY RECEIVED 012
06/05/2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 011
06/04/2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 010
06/04/2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 009
06/04/2007 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED 008
12/05/2006 GNRT F NON-FINAL ACTION E-MAILED 007
12/05/2006 CNRT R NON-FINAL ACTION WRITTEN 006
12/04/2006 DOCK D ASSIGNED TO EXAMINER 005
12/01/2006 ARAA I ATTORNEY REVOKED AND/OR APPOINTED 004
12/01/2006 REAP I TEAS REVOKE/APPOINT ATTORNEY RECEIVED 003
10/03/2006 MAFR O APPLICATION FILING RECEIPT MAILED 002
09/28/2006 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Michael N. Cohen
CORRESPONDENCE ADDRESS MICHAEL N. COHEN
LAW OFFICE OF MICHAEL N. COHEN, PC
9025 WILSHIRE BLVD.
SUITE 301
BEVERLY HILLS, CA 90211
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Auriga Laboratories, Inc.
ADDRESS 5555 Triangle Parkway, Suite 300
Norcross, GA 30092
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed